Evidence map›Paper›PMID 40410823›Full record

ArticleCancer imaging : the official publication of the International Cancer Imaging Society2025

Multimodal ultrasound-based radiomics and deep learning for differential diagnosis of O-RADS 4-5 adnexal masses.

Song Zeng, Haoran Jia, Hao Zhang, Xiaoyu Feng, Meng Dong, Lin Lin, XinLu Wang, Hua Yang

Abstract read
In one paragraph

Article in Cancer imaging : the official publication of the International Cancer Imaging Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. O-RADS for assessment of adnexal lesions: current status, challenges and future directions.Cancer imaging : the official publication of the International Cancer Imaging Society · 2026
    Review
  3. Article
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Song Zeng *Department of Ultrasound, Shengjing Hospital of China Medical University, Shenyang, China.
Haoran Jia *Department of Thoracic Surgery, Shengjing Hospital of China Medical University, Shenyang, China.
Hao ZhangDepartment of Ultrasound, Shengjing Hospital of China Medical University, Shenyang, China.
Xiaoyu FengDepartment of Ultrasound, Shengjing Hospital of China Medical University, Shenyang, China.
Meng DongDepartment of Ultrasound, Shengjing Hospital of China Medical University, Shenyang, China.
Lin LinDepartment of Ultrasound, Shengjing Hospital of China Medical University, Shenyang, China.
XinLu WangDepartment of Ultrasound, Shengjing Hospital of China Medical University, Shenyang, China. wangxl1@sj-hospital.org.
Hua YangDepartment of Ultrasound, Shengjing Hospital of China Medical University, Shenyang, China. yangh1@sj-hospital.org.

Funding

National Natural Science Foundation of China 82001846
6 · The paper itself

Abstract

backgroundAccurate differentiation between benign and malignant adnexal masses is crucial for patients to avoid unnecessary surgical interventions. Ultrasound (US) is the most widely utilized diagnostic and screening tool for gynecological diseases, with contrast-enhanced US (CEUS) offering enhanced diagnostic precision by clearly delineating blood flow within lesions. According to the Ovarian and Adnexal Reporting and Data System (O-RADS), masses classified as categories 4 and 5 carry the highest risk of malignancy. However, the diagnostic accuracy of US remains heavily reliant on the expertise and subjective interpretation of radiologists. Radiomics has demonstrated significant value in tumor differential diagnosis by extracting microscopic information imperceptible to the human eye. Despite this, no studies to date have explored the application of CEUS-based radiomics for differentiating adnexal masses. This study aims to develop and validate a multimodal US-based nomogram that integrates clinical variables, radiomics, and deep learning (DL) features to effectively distinguish adnexal masses classified as O-RADS 4-5.

methodsFrom November 2020 to March 2024, we enrolled 340 patients who underwent two-dimensional US (2DUS) and CEUS and had masses categorized as O-RADS 4-5. These patients were randomly divided into a training cohort and a test cohort in a 7:3 ratio. Adnexal masses were manually segmented from 2DUS and CEUS images. Using machine learning (ML) and DL techniques, five models were developed and validated to differentiate adnexal masses. The diagnostic performance of these models was evaluated using the area under the receiver operating characteristic (ROC) curve (AUC), accuracy, sensitivity, specificity, precision, and F1-score. Additionally, a nomogram was constructed to visualize outcome measures.

resultsThe CEUS-based radiomics model outperformed the 2DUS model (AUC: 0.826 vs. 0.737). Similarly, the CEUS-based DL model surpassed the 2DUS model (AUC: 0.823 vs. 0.793). The ensemble model combining clinical variables, radiomics, and DL features achieved the highest AUC (0.929).

conclusionsOur study confirms the effectiveness of CEUS-based radiomics for distinguishing adnexal masses with high accuracy and specificity using a multimodal US-based radiomics DL nomogram. This approach holds significant promise for improving the diagnostic precision of adnexal masses classified as O-RADS 4-5.

Indexed as

Adnexal DiseasesDeep LearningAdultAgedContrast MediaDiagnosis, DifferentialFemaleHumansMiddle AgedMultimodal ImagingNomogramsRadiomicsUltrasonographyContrast MediaAdnexal massesArtificial intelligenceContrast-enhanced ultrasoundDeep learningO-RADSRadiomics

Identifiers

PMID40410823
PMCPMC12100863

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.